Document is current
Any future updates will be listed below
-
Authors
Rogers, Leonard C.
Zhou, Jing
Baker, Adriana
Schutt, Charles R.
Panda, Prashanta K.
Van Tine, Brian A. https://orcid.org/0000-0003-4572-6668
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01-CA227115)
Sarcoma Foundation of America
CJ's Journey
Sarcoma Alliance for Research Through Collaboration
- License Information
-
More Information
Article History
Received: 20 July 2020
Accepted: 4 January 2021
First Online: 21 January 2021
Ethics approval and consent to participate
: Not applicable
: Not applicable
: B.A.V.T. declares grants from Merck; grants and personal fees from Pfizer; grants from TRACON Pharmaceuticals; grants, personal fees, and other from GlaxoSmithKline; personal fees from Polaris Inc.; personal fees from Lilly; personal fees from Caris Life Sciences; personal fees from Novartis; personal fees from CytRX; personal fees from Plexxikon; personal fees from Epizyme; personal fees from Daiichi Sankyo; personal fees from Adaptimmune; personal fees from Immune Design; personal fees from Bayer; personal fees from Cytokinetics; and personal fees from Deciphera and has a patent issued for the use of ME1 as a biomarker and ACXT3102. All other authors report no conflicts of interest.
